This receptor is expressed mainly on activated T cells and, upon binding to its ligands PD-L1 (CD274) and PD-L2 (CD273) in tumor cells, transmits inhibitory signals to T cells, thereby helping to maintain a balance between immune tolerance and tissue damage (Dong et al., 1999). This evidence concerns the gene PDCD1LG2 and neoplasm.